@cremieuxrecueil Melanoma mortality is absolutely down for stages 3/4 at presentation. Not sure about the incidence but I imagine there are a lot of competing risks that would cloud that trend over time (like smoking induced mortality)
@jasonryanmd Do you see a major gap in GDMT adoption for HF at this point? Any situations, even among the elderly that you feel uptake should be higher?
@MarcGoldwein Cost per beneficiary for current Medicare program is ~$12k per year. Cost for younger persons (at higher multiples of Medicare rates) is lower -- closer to $5k-6k per year though if Medicare rates were applied it could be about ~25% lower. Bigger issue is ensuring provider margin
@RxRegA Thanks for speaking out during the saga. You put into words what many were feeling. Here is hoping the future FDA pursues high standards and US healthcare financing can slowly heal from lax oversight on this front.
@itslennyj@CataPaul2@SpecialSitsNews You're missing something. What happens when one nation's demand isn't met from oil flowing through one specific channel?